The expression of EBV-encoded LMP1 in young patients with lupus nephritis

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 4, 2015, Pages 6073-6078

  Ding, Yan ^a,b   He, Xiaojie ^c   Liao, Wang ^a   Yi, Zhuwen ^c   Yang, Huilan ^d   Xiang, Wei ^b  

^a Hainan General Hospital   (China)

^b Department of Dermatology   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

Author keywords

EBV; LMP1; LN; SLE

Indexed keywords

AUTOANTIBODY; LATENT MEMBRANE PROTEIN 2;

ADOLESCENT; ARTICLE; CHILD; DISEASE DURATION; EPSTEIN BARR VIRUS INFECTION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROTEIN EXPRESSION;

HUMAN HERPESVIRUS 4;

EID: 84931291703     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Draborg AH, Duus K, Houen G. Epstein-Barr virus and systemic lupus erythematosus. Clini Dev Immunol 2012; 2012: 370516.
2. Giannico G, Fogo AB. Lupus nephritis: is the kidney biopsy currently necessary in the management of Lupus nephritis? Clin J Am Soc Nephro 2013; 8: 138-45.
3. Anders HJ, Fogo AB. Immunopathology of lupus nephritis. Semin Immunopathol 2014; 36: 443-59.
4. Doria A, Canova M, Tonon M, Zen M, Rampudda E, Bassi N, Atzeni F, Zampieri S, Ghirardello A. Infections as triggers and complications of systemic lupus erythematosus. Autoimmun Rev 2008; 8: 24-8.
5. Peters AL, Stunz LL, Meyerholz DK, Mohan C, Bishop GA. Latent membrane protein 1, the EBV-encoded oncogenic mimic of CD40, accelerates autoimmunity in B6.Sle1 mice. J Immunol 2010; 185: 4053-62.
6. Arcipowski KM, Bishop GA. Roles of the kinase TAK1 in TRAF6-dependent signaling by CD40 and its oncogenic viral mimic, LMP1. PLoS One 2012; 7: e42478.
7. Davidson A. Editorial: autoimmunity to vimentin and lupus nephritis. Arthritis Rheumatol 2014; 66: 3251-4.
8. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
9. Yu XX, Yao CW, Tao JL, Yang C, Luo MN, Li SM, Liu HF. The expression of renal Epstein-Barr virus markers in patients with lupus nephritis. Exp Ther Med 2014; 7: 1135-40.
10. Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004; 15: 241-50.
11. Borchers AT, Leibushor N, Naguwa SM, Cheema GS, Shoenfeld Y, Gershwin ME. Lupus nephritis: a critical review. Autoimmun Rev 2012; 12: 174-94.
12. James JA, Kaufman KM, Farris AD, Taylor-Albert E, Lehman TJ, Harley JB. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 1997; 100: 3019-26.
13. Houssiau FA, Lauwerys BR. Current management of lupus nephritis. Best Pract Res Clin Rheumatol 2013; 27: 319-28.
14. Dawson CW, Port RJ, Young LS. The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC). Semin Cancer Biol 2012; 22: 144-53.
15. Shariati-Sarabi Z, Ranjbar A, Monzavi SM, Esmaily H, Farzadnia M, Zeraati AA. Analysis of clinicopathologic correlations in Iranian patients with lupus nephritis. Int J Rheum Dis 2013; 16: 731-8.
16. Migliorini P, Baldini C, Rocchi V, Bombardieri S. Anti-Sm and anti-RNP antibodies. Autoimmun 2005; 38: 47-54.